Search results for "severity"

showing 10 items of 1287 documents

Evaluation of VTE-BLEED for predicting intracranial or fatal bleeding in stable anticoagulated patients with venous thromboembolism.

2018

VTE-BLEED predicts fatal and/or intracranial bleeding in patients with venous thromboembolism treated with long-term anticoagulants http://ow.ly/3hqg30iXK5a

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyMEDLINEHemorrhage030204 cardiovascular system & hematologySeverity of Illness Indexlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawPredictive Value of TestsRecurrenceSeverity of illnessMedicineHumansIn patientcardiovascular diseases030212 general & internal medicineAgedbusiness.industryAnticoagulantsVenous ThromboembolismBleedMiddle Agedequipment and suppliesPrognosisSurgeryPredictive value of testsDisease ProgressionFemalebusinessVenous thromboembolismIntracranial bleedingThe European respiratory journal
researchProduct

Predictors of need for noninvasive ventilation during respiratory tract infections in medically stable, non-ventilated subjects with amyotrophic late…

2014

BACKGROUND: Acute lower respiratory infections can impair muscle strength in patients with amyotrophic lateral sclerosis (ALS). When associated with an increase in load on the respiratory system, this situation may precipitate hypercapnic respiratory failure in non-ventilated patients with ALS. The aim of this study was to determine whether a clinical or functional parameter can predict the need for noninvasive ventilation (NIV) during an acute respiratory infection for medically stable, non-ventilated patients with ALS. METHODS: This was a prospective study involving all non-ventilated subjects with ALS admitted due to an acute respiratory infection to a respiratory care unit from a tertia…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyNeuromuscular diseaseVital CapacityCritical Care and Intensive Care MedicineSeverity of Illness IndexFEV1/FVC ratioPredictive Value of TestsmedicineOdds RatioHumansProspective StudiesAmyotrophic lateral sclerosisRespiratory systemRespiratory Tract InfectionsAgedNoninvasive VentilationRespiratory tract infectionsbusiness.industryAmyotrophic Lateral SclerosisRespiratory infectionInsufflationGeneral MedicineMiddle Agedmedicine.diseaseSurgeryLogistic ModelsRespiratory failureCoughAnesthesiaFemalebusinessRespiratory InsufficiencyRespiratory careRespiratory care
researchProduct

Serum Surfactant Protein D as a Marker of Asthma Severity

2016

Pulmonary and Respiratory MedicinePulmonary Surfactant-Associated Protein Abusiness.industryAsthma severitySurfactant protein DBiomarkerSettore MED/10 - Malattie Dell'Apparato Respiratoriomedicine.diseasePulmonary Surfactant-Associated Protein DCritical Care and Intensive Care MedicineAsthma03 medical and health sciences0302 clinical medicine030228 respiratory systemImmunologyMedicineHumans030212 general & internal medicinePulmonary Surfactant-Associated Protein DbusinessCardiology and Cardiovascular MedicineBiomarkersAsthmaPulmonary Surfactant-Associated Protein AHuman
researchProduct

Is the Parsonnet's score a good predictive score of mortality in adult cardiac surgery: assessment by a French multicentre study.

1997

Objecti6e: Parsonnet proposed a preoperative score (‘‘initial Parsonnet’s score’’, which predicts the hospital mortality of adult cardiac surgery. This score was then modified by including several risk factors used in the ‘SUMMIT’ system (‘‘modified Parsonnet’s score’’, 44 variables). We wanted to assess the predictive value of these two scores in a French surgical population. Methods: From December 1992 to April 1993, in France, we organised a prospective multicentre study on adult cardiac surgery mortality and morbidity. Data on 6649 patients were included. We analysed statistically the predictive value of each risk factor and of the two scores on mortality and morbidity at one month. Res…

Pulmonary and Respiratory MedicineScore testAdultMalePediatricsmedicine.medical_specialtyHeart DiseasesPopulationSeverity of Illness IndexPostoperative ComplicationsPredictive Value of TestsRisk FactorsCause of DeathSeverity of illnessMedicineHumansHospital MortalityProspective StudiesRisk factorProspective cohort studyeducationAgedAged 80 and overeducation.field_of_studybusiness.industryGeneral MedicineOdds ratioMiddle AgedPredictive value of testsTest scoreEmergency medicineSurgeryFemaleFranceCardiology and Cardiovascular MedicinebusinessEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
researchProduct

Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD.

2011

Two, once daily (q.d.) inhaled bronchodilators are available for the treatment of chronic obstructive pulmonary disease (COPD): the β(2)-agonist indacaterol and the anticholinergic tiotropium. This blinded study compared the efficacy of these two agents and assessed their safety and tolerability. Patients with moderate-to-severe COPD were randomised to treatment with indacaterol 150 μg q.d. (n=797) or tiotropium 18 μg q.d. (n=801) for 12 weeks. After 12 weeks, the two treatments had similar overall effects on "trough" (24 h post-dose) forced expiratory volume in 1 s. Indacaterol-treated patients had greater improvements in transition dyspnoea index (TDI) total score (least squares means 2.0…

Pulmonary and Respiratory MedicineSpirometryMalemedicine.drug_classScopolamine DerivativesQuinolonesSeverity of Illness IndexCholinergic AntagonistsDrug Administration ScheduleMedical Recordslaw.inventionPulmonary Disease Chronic ObstructiveRandomized controlled trialDouble-Blind MethodlawAdrenergic beta-2 Receptor AntagonistsForced Expiratory VolumemedicineAnticholinergicHumansTiotropium BromideAdverse effectAgedCOPDmedicine.diagnostic_testbusiness.industryTiotropium bromideMiddle Agedmedicine.diseaserespiratory tract diseasesBronchodilator AgentsTreatment OutcomeTolerabilitySpirometryAnesthesiaIndansIndacaterolFemalebusinessmedicine.drugThe European respiratory journal
researchProduct

Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study

2019

BACKGROUND: Small airways dysfunction (SAD) is well recognised in asthma, yet its role in the severity and control of asthma is unclear. This study aimed to assess which combination of biomarkers, physiological tests, and imaging markers best measure the presence and extent of SAD in patients with asthma.METHODS: In this baseline assessment of a multinational prospective cohort study (the Assessment of Small Airways Involvement in Asthma [ATLANTIS] study), we recruited participants with and without asthma (defined as Global Initiative for Asthma severity stages 1-5) from general practices, the databases of chest physicians, and advertisements at 29 centres across nine countries (Brazil, Chi…

Pulmonary and Respiratory MedicineSpirometrymedicine.medical_specialtySocio-culturaleSettore MED/10 - Malattie Dell'Apparato RespiratorioDISEASE03 medical and health sciences0302 clinical medicineQuality of lifeHYPERRESPONSIVENESSInternal medicineSeverity of illnessMedicine030212 general & internal medicineProspective cohort studyAsthmamedicine.diagnostic_testbusiness.industryasthmamedicine.diseaseNitrogen washoutrespiratory tract diseasessmall airways dysfunctionLUNG-MECHANICSSEVERITY030228 respiratory systemSalbutamolVENTILATION HETEROGENEITYbiomarkerAsthma; small airways dysfunctionbusinessmedicine.drugCohort study
researchProduct

Successful surgery of neuroendocrine carcinoma infiltrating right ventricle and pulmonary artery.

2020

We present the clinical case of a 60-year-old woman complained of dyspnea on exertion. Echocardiogram showed a giant mass in the right ventricle (RV) with obstruction to the outflow tract. Thorax computed tomography confirmed a mass of greater than 60 mm infiltrating RV and causing severe stenosis in the pulmonary artery, with severe pericardial effusion. Cardiac surgery was performed for tumor resection and pulmonary root replacement with a biological valved conduit. Histological analysis diagnosed a poorly differentiated large-cell neuroendocrine carcinoma. The patient had no immediate postoperative complications and has completed radiotherapy at a 9-month follow-up.

Pulmonary and Respiratory MedicineThoraxmedicine.medical_specialtymedicine.medical_treatmentHeart VentriclesConstriction Pathologic030204 cardiovascular system & hematologyPulmonary ArteryPericardial effusionSeverity of Illness IndexPericardial EffusionHeart Neoplasms03 medical and health sciencesBlood Vessel Prosthesis Implantation0302 clinical medicinemedicine.arterymedicineHumansNeuroendocrine carcinomaExertionCardiac Surgical Proceduresbusiness.industryMiddle Agedmedicine.diseaseSurgeryCardiac surgeryCarcinoma NeuroendocrineRadiation therapymedicine.anatomical_structureTreatment Outcome030228 respiratory systemVentricleEchocardiographyPulmonary arterySurgeryFemaleCardiology and Cardiovascular MedicinebusinessTomography X-Ray ComputedJournal of cardiac surgeryREFERENCES
researchProduct

484 Depression Reduces Chance for Clinical Improvement in Heart Transplant Candidates Independent of Disease Severity, Physical Activity and Eating H…

2011

Pulmonary and Respiratory MedicineTransplantationmedicine.medical_specialtyDisease severitybusiness.industryPhysical activityPhysical therapyMedicineSurgeryCardiology and Cardiovascular MedicinebusinessEating habitsDepression (differential diagnoses)The Journal of Heart and Lung Transplantation
researchProduct

Circulating CD34+ cells are decreased in chronic obstructive pulmonary disease.

2006

Pulmonary and Respiratory Medicineaged; antigens; biological markers; blood; blood/immunology; cd34; chronic obstructive; humans; pulmonary disease; severity of illness indexchronic obstructivebusiness.industryCd34 cellsPulmonary diseaseAntigens CD34cd34Severity of Illness IndexPulmonary Disease Chronic ObstructiveText miningantigensbloodImmunologyMedicineHumansblood/immunologybusinessbiological markersBiomarkerspulmonary diseaseAgedProceedings of the American Thoracic Society
researchProduct

The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update.

2009

SummarySevere persistent asthma causes a substantial morbidity and mortality burden and is frequently inadequately controlled despite intensive guideline-based therapy. Targeting allergic inflammatory processes that underlie the pathogenesis of severe persistent asthma improves asthma control in a significant proportion of patients. Omalizumab, a humanized monoclonal anti-immunoglobulin E (IgE) antibody, has been developed to target IgE, which is central to triggering and maintaining allergic airway inflammation. In a comprehensive program of clinical trials, omalizumab has been shown to reduce asthma exacerbation and emergency visit rates, and to improve quality of life in patients with se…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyAllergyAllergic asthmaOmalizumabOmalizumabImmunoglobulin EAntibodies Monoclonal HumanizedSeverity of Illness IndexDrug Administration ScheduleInternal medicineSeverity of illnessmedicineHumansDosingAnti-Asthmatic AgentsAsthmaClinical Trials as TopicbiologyDose-Response Relationship Drugbusiness.industryAntibodies MonoclonalGuidelineImmunoglobulin Emedicine.diseaseAsthmaAntibodies Anti-IdiotypicClinical trialImmunologybiology.proteinRespiratoryImmunoglobulin E (IgE)businessmedicine.drugRespiratory medicine
researchProduct